Indian pharma major Cipla Thursday announced the launch of RT-PCR test kit “ViraGen’ in partnership with another leading Indian manufacturer of diagnostic kits Kerala-based Ubio Biotechnology Systems. The supply of the kit will start from May 25. RT-PCR test is used to confirm the Covid-19 virus in the swab collected from the person. It is one of the most reliable tests available to check the presence of the virus. Currently, about 20 lakh tests are done per day. The union government is planning to take this capacity to about 40 lakhs per day by the end of June. PTI quoted Cipla MD and Global CEO Umang Vohra as saying, “Cipla has been working relentlessly to ensure accessibility to treatments in this fight against Covid-19. Guided by our core purpose of ‘Caring for Life’, this partnership will enable us to reach out to more people across the country at a crucial time like now”.
Download Organiser Mobile App:
Mobile App: https://play.google.com/store/apps/de...
Visit Us At:
Follow us on:
Background Music Credits: https://www.bensound.com
RSS Sarsanghchalak Dr Mohan Bhagwat said that population policy should be considered once again and that the policy should be made for the next 50 years. "The policy should be implemented equally, population imbalance has become a problem," Bhagwat said. “While reimagining the country’s development one predicament comes to the fore which appears to concern many. The rapid growth of the country’s population may give rise to many problems in the near fut ...